Breakingviews TV: IPO race...

Breakingviews TV: IPO race


Uber has joined Lyft in filing confidentially to go public. The urgency of the ride-hailing rivals is easily understood, explains Rob Cyran. Both companies continue to burn cash and widespread weakness in equities is prodding unicorns to tap the market while they can.

Breakingviews TV: No Huawei out

Dec 7 – At U.S. urging, Canada has arrested the CFO of Chinese telecom champion Huawei – who happens to be the daughter of founder Ren Zhengfei. Will Beijing retaliate against American CEOs next? Chris Beddor and Pete Sweeney put the move in trade-war perspective.

Read more


Breakingviews TV: Paris calls

France’s capital may currently be in the grip of social unrest, but it’s also the perfect vantage point for watching Europe’s gyrations – and sizing up Brexit from a respectful distance. Breakingviews’ global editor Rob Cox explains his recent decision to call Paris home.

Read more


Breakingviews TV: Motown’s back

Detroit is selling its first bonds since taking back financial control from the state. It marks a dramatic fiscal turnaround since the 2013 bankruptcy, but as Antony Currie explains, the city is still plagued by blight and faces big bills to repair its crumbling schools.

Read more


Breakingviews TV: Dinner date

After meeting in Argentina, Presidents Trump and Xi have called a 90-day ceasefire in the U.S.-China trade war. As Gina Chon explains, though, both the starting points for new talks and expectations for what they might achieve could easily be lost in translation.

Read more


Breakingviews TV: New gene baby

Nov 30 - A Chinese scientist sparked a firestorm by saying he had genetically altered human embryos using cutting-edge CRISPR technology. Robyn Mak and Jeffrey Goldfarb discuss what comes next amid the country’s biotech exuberance and a lack of proper oversight.

Read more


Breakingviews TV: Dying younger

American life expectancy has fallen for the third year in a row – even though the country spends more than many developed peers on healthcare. Opioids are one reason why. There’s reason to hope such deaths may now be peaking, Robert Cyran explains.

Read more


Breakingviews TV: Drug dreams

Moderna’s hoped-for $8 bln IPO valuation is a rich antidote to the funk hitting tech stocks. Rob Cyran explains that although the biotech firm’s technology is promising, it has no drugs near commercial readiness. That’s all the more reason to grab the money while it can.

Read more


Breakingviews TV: Breaking big

United Technologies is the latest to ditch the conglomerate life, while also closing a large acquisition. Antony Currie and Rob Cyran explain how a combination of activist pressure and the need for competitive scale is driving more giants to opt for heft over breadth.

Read more


Breakingviews TV: Soup coup

Activist Dan Loeb has cracked open the can at Campbell Soup – the U.S. company will give him board seats and a say in picking the next CEO. It’s enough to make a difference, provided Loeb can make nice with his former adversaries, explains Lauren Silva Laughlin.

Read more